دورية أكاديمية
Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer
| العنوان: | Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer |
|---|---|
| المؤلفون: | Han, Rui, Lu, Cong-hua, Hu, Chen, Dou, Yuan-yao, Kang, Jun, Lin, Cai-yu, Wu, Di, Jiang, Wei-ling, Yin, Guo-qing, He, YongAff1, IDs41401024012374_cor10 |
| المصدر: | Acta Pharmacologica Sinica. 45(6):1264-1275 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 16714083 17457254 |
|---|---|
| DOI: | 10.1038/s41401-024-01237-4 |